Overview Fundamentals API Earnings EOD API Sample Code Pricing

Insmed Inc (INSM NASDAQ) stock market data APIs

$75.66 -0.31(-0.4%) as of July 19, 2024
Price chart is built with Anychart

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.

Insmed Inc Financial Data Overview

12 392 M
163 M
315 M
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'INSM',
Type: 'Common Stock',
Name: 'Insmed Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BWM5P3',
CIK: '1104506',
EmployerIdNumber: '54-1972729',
FiscalYearEnd: 'December',
IPODate: '2000-06-01',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,

Insmed Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 315 M
  • EBITDA -671 894 976
  • Earnings Per Share -5.23
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Insmed Inc Earnings via APIs

  • Latest Release 2024-05-09
  • EPS/Forecast -1.23

Get Insmed Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?